Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson

Huberman Lab·March 18, 2026

OVERVIEW

This episode features Dr. Alex Marson discussing the current landscape of cancer treatment, focusing on the immune system and gene editing. He explains how advancements in biology, particularly CAR T-cell therapy and CRISPR, are revolutionizing the approach to treating and potentially curing various cancers by reprogramming the body's own defenses.

KEY TOPICS

  • The current state of cancer biology and treatment.
  • CAR T-cell therapy: programming immune cells to fight cancer.
  • The human immune system: innate vs. adaptive immunity, cell types, and function.
  • The role of the thymus in immune cell development and tolerance.
  • Autoimmune diseases: when the immune system attacks self.
  • Cancer as a genetic disease driven by accumulated mutations.
  • Environmental and lifestyle factors influencing cancer risk (mutagens).
  • Gene editing (CRISPR) as a tool to rewrite DNA for therapeutic purposes.
  • Immunotherapy breakthroughs, including checkpoint inhibitors and CAR T-cells.
  • Delivery methods for gene editing and targeted therapies (viral vectors, lipid nanoparticles).
  • Ethical considerations of germline gene editing.
  • The development of advanced techniques for understanding and engineering immune cells.

MAIN TAKEAWAYS

  • We are in an incredibly exciting moment in biology where the potential for curing diseases, especially cancer, is rapidly advancing.
  • The immune system's fundamental role is to distinguish "self" from "non-self" to protect the body from threats like infections and cancer.
  • CAR T-cell therapy and checkpoint inhibitors are already showing remarkable success in treating certain cancers by harnessing and redirecting the immune system.
  • CRISPR technology allows for precise editing of DNA, opening up possibilities to create new, highly effective cell-based therapies that were once science fiction.
  • Understanding how various lifestyle and environmental factors impact immune function is crucial, but this area is still under-explored mechanistically.
  • While ethical concerns exist, particularly with heritable (germline) gene editing, somatic cell gene editing in therapies is progressing rapidly into clinical trials.
  • The future of medicine involves programming the behavior of cells in a directed way, moving beyond traditional drugs to directly instruct our biology.
  • New technologies like single-cell RNA sequencing combined with CRISPR are providing unprecedented roadmaps to understand and engineer immune cells with high precision.

NOTABLE QUOTES

"We're living in this amazing moment of biology where we can put a gene that encodes something on the surface of T-cells that will make them programmed to search and destroy for cancer cells."
"There's really a step function in what's imaginable and achievable in medicine."
"It's kind of amazing how much we don't know about these determinants of immune health."
"We are peering over into what's next. Like what your children and my children and are probably our parents also will be able to benefit from in the next 10 years, maybe sooner."

Summarized with DriftNote — AI-powered podcast summaries

Try it free